当前位置:首页>>博士后之家>>国外博士后招聘>>正文内容

德国明斯特医学院恶性淋巴瘤的分子发病机制方向博士后研究科学家

2015年04月20日
来源:知识人网整理
摘要:

Postdoctoral Research Scientist : Munster, Germany

 

The University Hospital of Münster (UKM) is one of the leading university hospitals in Germany.
The Translational Oncology Unit (Head Professor Dr. Georg Lenz) that is associated with the Department of Internal Medicine A for Hematology and Oncology is offering a position as a

Postdoctoral Research Scientist
Ref 9191
(TV-L E13)

that is immediately available. The position is available initially for 2 years with the possibility of a subsequent permanent position to complement our highly motivated, young scientific research group. The research group of Professor Dr. Lenz has a long-standing interest in the analysis of the molecular pathogenesis of malignant lymphomas. Professor intends to further functionally validate the role of novel oncogenes and tumor suppressors in the biology of aggressive lymphomas.

Additional information can be found at:
http://campus.uni-muenster.de/tralon_start.html
http://www.ncbi.nlm.nih.gov/pubmed/25359993
http://www.ncbi.nlm.nih.gov/pubmed/24362935
http://www.ncbi.nlm.nih.gov/pubmed/23840064

Applicants must be highly motivated and possess a Ph.D. degree. Prior experience in lymphoma or leukemia research is prerequisite for candidates. Candidates must have an excellent understanding and extensive hands-on experience in biochemistry, molecular biology and cell biology with a record of publications.

We look forward to receiving your application. We prefer receiving your application by e-mail. Please send your application to bewerbung@ukmuenster.de citing the reference code. Alternatively, you can send your application by mail to Verwaltung des Universitätsklinikums Münster, Albert-Schweitzer-Campus 1, Gebäude D5, 48149 Münster, Germany.

Applications of women are specifically invited. In the case of similar qualifications, competence, and specific achievements, women will be considered on preferential terms within the framework of the legal possibilities. Handicapped candidates with equivalent qualifications will be given preference.

Posted: April 15, 2015
Expires: April 30, 2015